Publications 2019 (11)
-
Speck-Planche A*, Scotti MT. BET bromodomain inhibitors: fragment-based in silico design using multi-target QSAR models. Mol Divers 2019: (en Premsa).
-
Ronzano F*, Gutiérrez-Sacristán A, Furlong LI*. Comorbidity4j: a tool for interactive analysis of disease comorbidities over large patient datasets. Bioinformatics 2019: (en Premsa).
-
Speck-Planche A*. Multiple Perspectives in Anti-cancer Drug Discovery: From old Targets and Natural Products to Innovative Computational Approaches. Anticancer Agents Med Chem 2019; 19(2): 146-147.
-
Aguirre-Plans J, Piñero J, Sanz F, Furlong LI, Fernandez-Fuentes N, Oliva B*, Guney E*. GUILDify v2.0: A tool to identify molecular networks underlying human diseases, their comorbidities and their druggable targets. J Mol Biol 2019; 431(13): 2477-2484.
-
Leis A, Ronzano F, Mayer MA, Furlong LI, Sanz F*. Detecting Signs of Depression in Tweets in Spanish: Behavioral and Linguistic Analysis. J Med Internet Res 2019; 21(6): e14199.
-
Nevado-Holgado AJ*, Ribe E, Thei L, Furlong LI, Mayer MA, Quan J, Richardson JC, Cavanagh J, Consortium N, Lovestone S. Genetic and Real-World Clinical Data, Combined with Empirical Validation, Nominate Jak-Stat Signaling as a Target for Alzheimer's Disease Therapeutic Development. Cells 2019; 8(5): 425.
-
Casas AI*, Hassan AA, Larsen SJ, Gomez-Rangel V, Elbatreek M, Kleikers PWM, Guney E, Egea J, López MG, Baumbach J, Schmidt HHHW. From single drug targets to synergistic network pharmacology in ischemic stroke. Proc Natl Acad Sci U S A 2019; 116(14): 7129-7136.
-
Gomez-Rubio P, Piñero J, Molina-Montes E, Gutiérrez-Sacristán A, Marquez M, Rava M, Michalski CW, Farré A, Molero X, Löhr M, Perea J, Greenhalf W, O'Rorke M, Tardón A, Gress T, Barberà VM, Crnogorac-Jurcevic T, Muñoz-Bellvís L, Domínguez-Muñoz E, Balsells J, Costello E, Yu J, Iglesias M, Ilzarbe L, Kleeff J, Kong B, Mora J, Murray L, O'Driscoll D, Poves I, Lawlor RT, Ye W, Hidalgo M, Scarpa A, Sharp L, Carrato A, Real FX, Furlong LI, Malats N*, PanGenEU Study Investigators. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches. Int J Cancer 2019; 144(7): 1540-1549.
-
Gea J*, Pascual S, Castro-Acosta AA, Hernández-Carcereny C, Castelo R, Marquez-Martin E, Montón C, Palou A, Faner R, Furlong LI, Seijo L, Sanz F, Torà M, Vilaplana C, Casadevall C, López-Campos JL, Monsó E, Peces-Barba G, Cosio BG, Agustí A, Anexo. Miembros del grupo BIOMEPOC. The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease. Arch Bronconeumol 2019; 55(2): 93-99.
-
Del-Toro N, Duesbury M, Koch M, Perfetto L, Shrivastava A, Ochoa D, Wagih O, Piñero J, Kotlyar M, Pastrello C, Beltrao P, Furlong LI, Jurisica I, Hermjakob H, Orchard S, Porras P*, IMEx Consortium contributing authors. Capturing variation impact on molecular interactions in the IMEx Consortium mutations data set. Nat Commun 2019; 10(1): 10.
-
Pérez-Granado J, Piñero J, Furlong LI*. ResMarkerDB: a database of biomarkers of response to antibody therapy in breast and colorectal cancer. Database (Oxford) 2019; 2019: baz060.
